Showing results (1-10 of 39) with videos related to
Sort By:
Pageof 4
Frontiers in Pharmacology|August 5, 2025
Looking beyond silybin: the importance of other silymarin flavonolignansMichal Selc, Andrea BabelovaDrug Design, Development and Therapy|October 24, 2024
Novel Strategies Enhancing Bioavailability and Therapeutical Potential of Silibinin for Treatment of Liver DisordersMichal Selc, Radka Macova, Andrea BabelovaPlanta|November 5, 2025
Therapeutic potential of medicinal plant sprouts: emerging opportunities and challenges in phytochemistryDominika Melegova, Andrea Babelova, Michal SelcCurrent Opinion in Pharmacology|February 14, 2013
Anti-atherosclerotic mechanisms of statin therapyAndrea Babelova, Daniel G Sedding, Ralf P BrandesDiscover Oncology|August 8, 2025
Isosilybin B: a potential novel therapeutic agent with hepatoprotective, anticancer and antifibrotic propertiesMichal Selc, Kristina Jakic, Radka Macova, et al.Journal of Diabetes Research|February 25, 2015
Sex-differences in renal expression of selected transporters and transcription factors in lean and obese Zucker spontaneously hypertensive fatty ratsAndrea Babelova, Birgitta C Burckhardt, Waja Wegner, et al.Hypertension (Dallas, Tex. : 1979)|October 2, 2013
L-type calcium channel inhibitor diltiazem prevents aneurysm formation by blood pressure-independent anti-inflammatory effectsAnja Mieth, Marc Revermann, Andrea Babelova, et al.Genomics|July 23, 2015
Next generation sequencing of sex-specific genes in the livers of obese ZSF1 ratsAndrea Babelova, Birgitta C Burckhardt, Gabriela Salinas-Riester, et al.Heliyon|November 24, 2022
Plate reader spectroscopy as an alternative to atomic absorption spectroscopy for the assessment of nanoparticle cellular uptakeBarbora Svitkova, Michal Selc, Veronika Nemethova, et al.Neoplasma|July 27, 2023
Effects of different-sized silver nanoparticles on morphological and functional alterations in lung cancer and non-cancer lung cellsKristina Jakic, Michal Selc, Radka Macova, et al.Pageof 4